What should you know about pt2b melanoma?

The pT label concerns the original skin tumour. T2 refers to its measured thickness range, and b means ulceration was seen in the primary melanoma. Ulceration is a pathology finding in the surface covering of the tumour; it is not the same as a wound caused by scratching or a biopsy. This category does not independently confirm lymph-node or distant spread.

The full report may also describe margins, the tumour site, and other microscopic features. A skin cancer team uses those details, examination findings, and any appropriate tests to create the complete stage and treatment plan.

Ask whether the diagnostic biopsy removed the whole visible lesion and whether a wider surgical excision is needed. Because pT2b includes an ulcerated primary tumour, your specialist may discuss sentinel lymph node biopsy to examine the first draining node pathway. The choice depends on the pathology, location, health, and preferences, so ask what information the procedure would add.

Keep all appointments, protect the healing site from sun, and report changes in nearby skin or lymph-node areas. Do not apply creams or attempt further removal unless the treating team advises it.

Call the clinic promptly for a new or changing pigmented area, a firm lump near the scar, or repeated bleeding. After a procedure, worsening redness, heat, swelling, drainage, fever, wound separation, or escalating pain needs clinical advice. Sudden weakness, new confusion, a seizure, loss of balance, or a severe headache requires emergency assessment; these signs do not establish a diagnosis but should be treated urgently.

Ask what ulceration means in your report, whether margins are clear, what further excision is recommended, and whether sentinel lymph node biopsy is suitable. Clarify who will coordinate follow-up, how to examine your skin, and which symptoms should trigger an urgent call.